Fibrinolysis mediated by tissue plasminogen activator. Disclosure of a kinetic transition
- PMID: 3158522
- DOI: 10.1111/j.1432-1033.1985.tb08911.x
Fibrinolysis mediated by tissue plasminogen activator. Disclosure of a kinetic transition
Abstract
The rate of 'Glu'-plasminogen activation by tissue plasminogen activator was repeatedly determined during a fibrinolytic process. The process was found to proceed via two distinct phases. The kinetics of each phase obeyed Michaelis-Menten equation: First phase; kcat about 0.17 s-1 and Km about 1 microM, second phase; kcat about 0.13 s-1 and Km about 0.06 microM. Practically identical results were obtained with one-chain as with two-chain tissue plasminogen activator. Transition from first to second phase occurred when the system had been exposed to a certain degree of plasmin digestion. Electrophoretic analysis demonstrated time correlation between the appearance of minimally degraded fibrin (X-fragments) and the transition. No such correlation was found between transition and conversion of 'Glu'-plasminogen to 'Lys'-plasminogen. The effect can result in an acceleration (up to 13-fold) of the fibrinolytic process once a slight degradation of the fibrin has taken place. In vivo, the effect described may constitute a mechanism that protects a fibrin clot from premature lysis.
Similar articles
-
Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis.Eur J Biochem. 1984 May 2;140(3):513-22. doi: 10.1111/j.1432-1033.1984.tb08132.x. Eur J Biochem. 1984. PMID: 6233145
-
Studies on the kinetics of plasminogen activation by tissue plasminogen activator.Biochim Biophys Acta. 1982 Jun 24;704(3):461-9. doi: 10.1016/0167-4838(82)90068-1. Biochim Biophys Acta. 1982. PMID: 6214279
-
Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.Thromb Haemost. 2015 Jun;113(6):1278-88. doi: 10.1160/TH14-09-0771. Epub 2015 Mar 19. Thromb Haemost. 2015. PMID: 25789495
-
[Plasminogen activation and regulation of fibrinolysis].Nihon Rinsho. 2014 Jul;72(7):1218-23. Nihon Rinsho. 2014. PMID: 25163311 Review. Japanese.
-
Plasminogen activators: pharmacology and therapy.Radiology. 1990 Mar;174(3 Pt 2):993-1001. doi: 10.1148/radiology.174.3.174-3-993. Radiology. 1990. PMID: 2137641 Review.
Cited by
-
The sequence 581Ser-610Val in the fibrinogen Aα chain is responsible for the formation of complexes between plasminogen and αC-regions of fibrin(ogen).Heliyon. 2024 Nov 30;10(23):e40852. doi: 10.1016/j.heliyon.2024.e40852. eCollection 2024 Dec 15. Heliyon. 2024. PMID: 39687172 Free PMC article.
-
Kinetic studies on the effect of heparin and fibrin on plasminogen activators.Biochem J. 1988 Jan 1;249(1):77-81. doi: 10.1042/bj2490077. Biochem J. 1988. PMID: 2449177 Free PMC article.
-
Fibrin structures during tissue-type plasminogen activator-mediated fibrinolysis studied by laser light scattering: relation to fibrin enhancement of plasminogen activation.Eur Biophys J. 1994;23(4):239-52. doi: 10.1007/BF00213574. Eur Biophys J. 1994. PMID: 7805626
-
The plasminogen-plasmin system in malignancy.Cancer Metastasis Rev. 1992 Nov;11(3-4):291-311. doi: 10.1007/BF01307184. Cancer Metastasis Rev. 1992. PMID: 1423820 Review.
-
Effects of clot contraction on clot degradation: A mathematical and experimental approach.Biophys J. 2022 Sep 6;121(17):3271-3285. doi: 10.1016/j.bpj.2022.07.023. Epub 2022 Aug 3. Biophys J. 2022. PMID: 35927957 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources